Imagine having a high-tech lab that fits in a backpack and runs on a laptop. Instead of sending samples to a distant city and waiting weeks for results, doctors can identify germs and antibiotic resistance right where the patient is. It's like moving from sending a letter by mail to sending an instant text message for medical diagnosis.
Traditional infectious disease sampling in remote, high-migration areas is logistically difficult and lacks real-time value for local patient care. Large genomic data files cannot be easily transferred over weak internet connections to central labs.
A system combining field-deployable nanopore sequencing with laptop-based bioinformatics that transmits only the analysis results via mobile networks.
If you are a POCT developer dealing with the lack of diagnostic tools in remote areas — this project developed laptop-based bioinformatics and field-deployable sequencing that provides immediate results for direct patient care.
If you are a software provider dealing with the difficulty of transferring massive genomic data over poor networks — this project developed a way to share only the analytic output via mobile net, removing the need for high-performance computing.
If you are an agency dealing with unknown antimicrobial resistance (AMR) patterns in high-migration zones — this project developed a real-time linking system between frontline sites and central hubs to identify local drivers of AMR.
Based on available project data, specific pricing for the bioinformatics tools or sequencing kits is not provided; only the total EU contribution of EUR 5,207,500 is listed.
The project demonstrates scalability by establishing sequencing across 6 countries and linking them to a central hub in Tanzania.
Based on available project data, there is no mention of specific patents or licensing agreements for the newly developed bioinformatics solutions.
It integrates by using mobile networks to send analytic outputs from laptops in the field directly to public health authorities.
The project period runs from 2023-07-01 to 2028-06-30, indicating a multi-year development and implementation phase.
The consortium is heavily research-oriented, consisting of 10 partners across 8 countries. With 4 universities and 3 research institutes, the technical expertise is high, but the industrial presence is low at only 1 company (10% ratio), suggesting the current focus is on validation rather than immediate commercialization.
Contact Danmarks Tekniske Universitet (DTU) regarding the bioinformatics workflow.
Contact us to explore licensing opportunities for the field-deployable bioinformatics tools.
